{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:46:43Z","timestamp":1787582803138,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11904-016-0329-5","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T05:32:47Z","timestamp":1470115967000},"page":"279-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV"],"prefix":"10.1007","volume":"13","author":[{"given":"Bassem","family":"Matta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"issue":"1","key":"329_CR1","first-page":"27","volume":"4","author":"M Puoti","year":"2002","unstructured":"Puoti M et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev. 2002;4(1):27\u201335.","journal-title":"AIDS Rev"},{"issue":"1","key":"329_CR2","doi-asserted-by":"crossref","first-page":"150-","DOI":"10.1086\/520144","volume":"29","author":"CT Staples Jr","year":"1999","unstructured":"Staples Jr CT, Rimland D, Dudas D. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis. 1999;29(1):150-\u20134.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"329_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-138-3-200302040-00012","volume":"138","author":"MS Sulkowski","year":"2003","unstructured":"Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected Person. Ann Intern Med. 2003;138(3):197\u2013207.","journal-title":"Ann Intern Med"},{"issue":"2","key":"329_CR4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/589294","volume":"47","author":"G Guaraldi","year":"2008","unstructured":"Guaraldi G et al. Nonalcoholic fatty liver disease in hiv-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Clin Infect Dis. 2008;47(2):250\u20137.","journal-title":"Clin Infect Dis"},{"issue":"9349","key":"329_CR5","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio CL et al. HIV-1, hepatitis b virus, and risk of liver-related mortality in the multicenter cohort study (MACS). Lancet. 2002;360(9349):1921\u20136.","journal-title":"Lancet"},{"issue":"25","key":"329_CR6","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","volume":"364","author":"HR Rosen","year":"2011","unstructured":"Rosen HR. Clinical practice. Chronic hepatitis C infection. N Engl J Med. 2011;364(25):2429\u201338.","journal-title":"N Engl J Med"},{"issue":"15","key":"329_CR7","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","volume":"22","author":"HH Thein","year":"2008","unstructured":"Thein HH et al. Natural history of hepatitis c virus infection in HIV-infected individuals and the impact of hiv in the era of highly active antiretroviral therapy: a meta-analysis. AIDS. 2008;22(15):1979\u201391.","journal-title":"AIDS"},{"issue":"3","key":"329_CR8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.26741","volume":"59","author":"MA Konerman","year":"2014","unstructured":"Konerman MA et al. Fibrosis progression in human immunodeficiency virus\/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs. Hepatology. 2014;59(3):767\u201375.","journal-title":"Hepatology"},{"issue":"4","key":"329_CR9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.23136","volume":"50","author":"J Macias","year":"2009","unstructured":"Macias J et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus\/hepatitis C virus. Hepatology. 2009;50(4):1056\u201363.","journal-title":"Hepatology"},{"issue":"1","key":"329_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","volume":"63","author":"European Association for Study of, L","year":"2015","unstructured":"European Association for Study of, L. EASL recommendations on treatment of hepatitis C 2015. J Hepatol. 2015;63(1):199\u2013236.","journal-title":"J Hepatol"},{"issue":"11","key":"329_CR11","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/gutjnl-2015-310421","volume":"64","author":"F Zoulim","year":"2015","unstructured":"Zoulim F et al. Hepatitis C virus treatment in the real world: optimising treatment and access to therapies. Gut. 2015;64(11):1824\u201333.","journal-title":"Gut"},{"issue":"8","key":"329_CR12","doi-asserted-by":"crossref","first-page":"e0135645","DOI":"10.1371\/journal.pone.0135645","volume":"10","author":"A Do","year":"2015","unstructured":"Do A et al. Drug authorization for sofosbuvir\/ledipasvir (harvoni) for chronic HCV infection in a real-world cohort: a new barrier in the HCV care cascade. PLoS One. 2015;10(8):e0135645.","journal-title":"PLoS One"},{"issue":"3","key":"329_CR13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/M15-0320","volume":"163","author":"LA Canary","year":"2015","unstructured":"Canary LA, Klevens RM, Holmberg SD. Limited access to new hepatitis C virus treatment under state medicaid programs. Ann Intern Med. 2015;163(3):226\u20138.","journal-title":"Ann Intern Med"},{"issue":"3","key":"329_CR14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","volume":"62","author":"AIHG Panel","year":"2015","unstructured":"Panel AIHG. Hepatitis C guidance: AASLD-idsa recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62(3):932\u201354.","journal-title":"Hepatology"},{"issue":"32","key":"329_CR15","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","volume":"20","author":"G Sebastiani","year":"2014","unstructured":"Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol. 2014;20(32):11033\u201353.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"329_CR16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","volume":"142","author":"L Castera","year":"2012","unstructured":"Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142(6):1293\u2013302. e4.","journal-title":"Gastroenterology"},{"issue":"3","key":"329_CR17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC et al. Liver biopsy. Hepatology. 2009;49(3):1017\u201344.","journal-title":"Hepatology"},{"issue":"6","key":"329_CR18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0016-5107(96)70192-X","volume":"43","author":"J Poniachik","year":"1996","unstructured":"Poniachik J et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc. 1996;43(6):568\u201371.","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"329_CR19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/jhep.2003.50223","volume":"37","author":"NH Afdhal","year":"2003","unstructured":"Afdhal NH. Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests? Hepatology. 2003;37(5):972\u20134.","journal-title":"Hepatology"},{"issue":"1","key":"329_CR20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2005.02.025","volume":"43","author":"TB Kelleher","year":"2005","unstructured":"Kelleher TB et al. Prediction of hepatic fibrosis in HIV\/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol. 2005;43(1):78\u201384.","journal-title":"J Hepatol"},{"issue":"3","key":"329_CR21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1373\/49.3.450","volume":"49","author":"E Rossi","year":"2003","unstructured":"Rossi E et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem. 2003;49(3):450\u20134.","journal-title":"Clin Chem"},{"issue":"4 Pt 1","key":"329_CR22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","volume":"36","author":"X Forns","year":"2002","unstructured":"Forns X et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36(4 Pt 1):986\u201392.","journal-title":"Hepatology"},{"issue":"3","key":"329_CR23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"ZH Lin","year":"2011","unstructured":"Lin ZH et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726\u201336.","journal-title":"Hepatology"},{"issue":"3","key":"329_CR24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.21835","volume":"46","author":"AA Shaheen","year":"2007","unstructured":"Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology. 2007;46(3):912\u201321.","journal-title":"Hepatology"},{"issue":"6","key":"329_CR25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"10","key":"329_CR26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2893.2006.00743.x","volume":"13","author":"C Christensen","year":"2006","unstructured":"Christensen C et al. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients. J Viral Hepat. 2006;13(10):652\u20138.","journal-title":"J Viral Hepat"},{"issue":"10","key":"329_CR27","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1373\/clinchem.2005.048389","volume":"51","author":"LA Adams","year":"2005","unstructured":"Adams LA et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51(10):1867\u201373.","journal-title":"Clin Chem"},{"issue":"6","key":"329_CR28","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep.20935","volume":"42","author":"P Cales","year":"2005","unstructured":"Cales P et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005;42(6):1373\u201381.","journal-title":"Hepatology"},{"issue":"2","key":"329_CR29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2013.03.016","volume":"59","author":"R Lichtinghagen","year":"2013","unstructured":"Lichtinghagen R et al. The enhanced liver fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol. 2013;59(2):236\u201342.","journal-title":"J Hepatol"},{"issue":"9","key":"329_CR30","doi-asserted-by":"crossref","first-page":"e0138838","DOI":"10.1371\/journal.pone.0138838","volume":"10","author":"P Schmid","year":"2015","unstructured":"Schmid P et al. Progression of liver fibrosis in HIV\/hcv co-infection: a comparison between non-invasive assessment methods and liver biopsy. PLoS One. 2015;10(9):e0138838.","journal-title":"PLoS One"},{"issue":"5","key":"329_CR31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00002030-200303280-00010","volume":"17","author":"RP Myers","year":"2003","unstructured":"Myers RP et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS. 2003;17(5):721\u20135.","journal-title":"AIDS"},{"issue":"19","key":"329_CR32","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.283.19.2526","volume":"283","author":"MS Sulkowski","year":"2000","unstructured":"Sulkowski MS et al. Elevated liver enzymes following initiation of antiretroviral therapy. JAMA. 2000;283(19):2526\u20137.","journal-title":"JAMA"},{"issue":"3","key":"329_CR33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.2005.065904","volume":"55","author":"J Macias","year":"2006","unstructured":"Macias J et al. Prediction of liver fibrosis in human immunodeficiency virus\/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut. 2006;55(3):409\u201314.","journal-title":"Gut"},{"issue":"8","key":"329_CR34","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1572-0241.2008.01954.x","volume":"103","author":"MA Loko","year":"2008","unstructured":"Loko MA et al. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 aquitaine cohort. Am J Gastroenterol. 2008;103(8):1973\u201380.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"329_CR35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2008.01.025","volume":"48","author":"P Cacoub","year":"2008","unstructured":"Cacoub P et al. Comparison of non-invasive liver fibrosis biomarkers in HIV\/HCV co-infected patients: the fibrovic study\u2014ANRS HC02. J Hepatol. 2008;48(5):765\u201373.","journal-title":"J Hepatol"},{"issue":"7","key":"329_CR36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1468-1293.2009.00812.x","volume":"11","author":"J Macias","year":"2010","unstructured":"Macias J et al. Use of simple noninvasive biomarkers to predict liver fibrosis in HIV\/HCV coinfection in routine clinical practice. HIV Med. 2010;11(7):439\u201347.","journal-title":"HIV Med"},{"issue":"2","key":"329_CR37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2010.03.007","volume":"53","author":"P Cales","year":"2010","unstructured":"Cales P et al. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV\/HCV co-infection. J Hepatol. 2010;53(2):238\u201344.","journal-title":"J Hepatol"},{"issue":"1","key":"329_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5604\/16652681.1184197","volume":"15","author":"DA Kliemann","year":"2015","unstructured":"Kliemann DA et al. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients. Ann Hepatol. 2015;15(1):27\u201332.","journal-title":"Ann Hepatol"},{"key":"329_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-230X-11-44","volume":"11","author":"W Ahmad","year":"2011","unstructured":"Ahmad W et al. A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol. 2011;11:44.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"329_CR40","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1182\/blood.V91.9.3239","volume":"91","author":"JL Cole","year":"1998","unstructured":"Cole JL et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood. 1998;91(9):3239\u201346.","journal-title":"Blood"},{"issue":"1","key":"329_CR41","first-page":"36","volume":"5","author":"N Kontorinis","year":"2003","unstructured":"Kontorinis N, Dieterich D. Hepatotoxicity of antiretroviral therapy. AIDS Rev. 2003;5(1):36\u201343.","journal-title":"AIDS Rev"},{"issue":"Suppl 2","key":"329_CR42","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/381453","volume":"38","author":"M Bonacini","year":"2004","unstructured":"Bonacini M. Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection. Clin Infect Dis. 2004;38 Suppl 2:S104\u20138.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"329_CR43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jac\/dkl524","volume":"59","author":"A Rivero","year":"2007","unstructured":"Rivero A, Mira JA, Pineda JA. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors. J Antimicrob Chemother. 2007;59(3):342\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"329_CR44","first-page":"107","volume":"7","author":"J Wilder","year":"2014","unstructured":"Wilder J, Patel K. The clinical utility of FibroScan((R)) as a noninvasive diagnostic test for liver disease. Med Devices (Auckl). 2014;7:107\u201314.","journal-title":"Med Devices (Auckl)"},{"issue":"3","key":"329_CR45","first-page":"303","volume":"18","author":"M Lupsor","year":"2009","unstructured":"Lupsor M et al. Performance of a new elastographic method (arfi technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary Results J Gastrointest Liver Dis. 2009;18(3):303\u201310.","journal-title":"Preliminary Results J Gastrointest Liver Dis"},{"issue":"4","key":"329_CR46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1478-3231.2009.02130.x","volume":"30","author":"H Takahashi","year":"2010","unstructured":"Takahashi H et al. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int. 2010;30(4):538\u201345.","journal-title":"Liver Int"},{"issue":"1","key":"329_CR47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mri.2014.10.003","volume":"33","author":"S Ichikawa","year":"2015","unstructured":"Ichikawa S et al. Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn Reson Imaging. 2015;33(1):26\u201330.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"329_CR48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"European Association for Study of, L. and H","year":"2015","unstructured":"European Association for Study of, L. and H. Asociacion Latinoamericana Para el Estudio del, EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237\u201364.","journal-title":"J Hepatol"},{"issue":"2","key":"329_CR49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Castera","year":"2005","unstructured":"Castera L et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343\u201350.","journal-title":"Gastroenterology"},{"issue":"2","key":"329_CR50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.qai.0000194238.15831.c7","volume":"41","author":"V Ledinghen de","year":"2006","unstructured":"de Ledinghen V et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV\/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2006;41(2):175\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"329_CR51","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1086\/521857","volume":"45","author":"S Vergara","year":"2007","unstructured":"Vergara S et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis. 2007;45(8):969\u201374.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"329_CR52","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/597350","volume":"48","author":"GD Kirk","year":"2009","unstructured":"Kirk GD et al. Assessment of liver fibrosis by transient elastography in persons with hepatitis C Virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis. 2009;48(7):963\u201372.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"329_CR53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2893.2009.01180.x","volume":"17","author":"M Sanchez-Conde","year":"2010","unstructured":"Sanchez-Conde M et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV\/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat. 2010;17(4):280\u20136.","journal-title":"J Viral Hepat"},{"issue":"4","key":"329_CR54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/QAI.0b013e3181acb675","volume":"51","author":"JA Pineda","year":"2009","unstructured":"Pineda JA et al. Liver stiffness as a predictor of esophageal varices requiring therapy in HIV\/hepatitis C virus-coinfected patients with cirrhosis. J Acquir Immune Defic Syndr. 2009;51(4):445\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"329_CR55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/hiv.12082","volume":"15","author":"L Castera","year":"2014","unstructured":"Castera L et al. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV\/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration. HIV Med. 2014;15(1):30\u20139.","journal-title":"HIV Med"},{"issue":"1","key":"329_CR56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2009.10.010","volume":"47","author":"P Sellier","year":"2010","unstructured":"Sellier P et al. Description of liver disease in a cohort of HIV\/HBV coinfected patients. J Clin Virol. 2010;47(1):13\u20137.","journal-title":"J Clin Virol"},{"issue":"1","key":"329_CR57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1365-2141.1999.01510.x","volume":"106","author":"H Hjorth-Hansen","year":"1999","unstructured":"Hjorth-Hansen H, Waage A, Borset M. Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells. Br J Haematol. 1999;106(1):28\u201334.","journal-title":"Br J Haematol"},{"issue":"1","key":"329_CR58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"EASL-ALEH Clinical Practice Guidelines","year":"2015","unstructured":"Clinical Practice Guidelines EASL-ALEH. Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237\u201364.","journal-title":"J Hepatol"},{"issue":"6","key":"329_CR59","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2009.01.022","volume":"50","author":"J Bottero","year":"2009","unstructured":"Bottero J et al. Performance of 11 biomarkers for liver fibrosis assessment in HIV\/HBV co-infected patients. J Hepatol. 2009;50(6):1074\u201383.","journal-title":"J Hepatol"},{"issue":"1","key":"329_CR60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-5926-3-8","volume":"3","author":"T Poynard","year":"2004","unstructured":"Poynard T et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol. 2004;3(1):8.","journal-title":"Comp Hepatol"},{"issue":"38","key":"329_CR61","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.3748\/wjg.v16.i38.4832","volume":"16","author":"I Sporea","year":"2010","unstructured":"Sporea I et al. Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J Gastroenterol. 2010;16(38):4832\u20137.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"329_CR62","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1478-3231.2011.02660.x","volume":"32","author":"AC Cardoso","year":"2012","unstructured":"Cardoso AC et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012;32(4):612\u201321.","journal-title":"Liver Int"},{"issue":"1","key":"329_CR63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2893.2010.01275.x","volume":"18","author":"P Miailhes","year":"2011","unstructured":"Miailhes P et al. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV\/HBV-coinfected patients. J Viral Hepat. 2011;18(1):61\u20139.","journal-title":"J Viral Hepat"},{"issue":"5","key":"329_CR64","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/QAI.0b013e318198a88a","volume":"50","author":"N Crum-Cianflone","year":"2009","unstructured":"Crum-Cianflone N et al. Nonalcoholic fatty liver disease among HIV-infected persons. J Acquir Immune Defic Syndr. 2009;50(5):464\u201373.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"329_CR65","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/hep.22665","volume":"49","author":"P Ingiliz","year":"2009","unstructured":"Ingiliz P et al. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy. Hepatology. 2009;49(2):436\u201342.","journal-title":"Hepatology"},{"issue":"5","key":"329_CR66","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ajg.2014.32","volume":"109","author":"JC Price","year":"2014","unstructured":"Price JC et al. Risk factors for fatty liver in the multicenter AIDS cohort study. Am J Gastroenterol. 2014;109(5):695\u2013704.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"329_CR67","first-page":"89","volume":"16","author":"C Grunfeld","year":"2008","unstructured":"Grunfeld C. Insulin resistance in HIV infection: drugs, host responses, or restoration to health? Top HIV Med. 2008;16(2):89\u201393.","journal-title":"Top HIV Med"},{"issue":"3","key":"329_CR68","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","volume":"14","author":"A Carr","year":"2000","unstructured":"Carr A et al. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS. 2000;14(3):F25\u201332.","journal-title":"AIDS"},{"issue":"10","key":"329_CR69","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"329_CR70","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson S et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59(9):1265\u20139.","journal-title":"Gut"},{"issue":"7","key":"329_CR71","first-page":"1682","volume":"103","author":"VW Wong","year":"2008","unstructured":"Wong VW et al. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am J Gastroenterol. 2008;103(7):1682\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"329_CR72","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/cid\/civ101","volume":"60","author":"CG Morse","year":"2015","unstructured":"Morse CG et al. Nonalcoholic steatohepatitis and hepatic fibrosis in HIV-1-monoinfected adults with elevated aminotransferase levels on antiretroviral therapy. Clin Infect Dis. 2015;60(10):1569\u201378.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"329_CR73","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/ajg.2012.331","volume":"107","author":"VW Wong","year":"2012","unstructured":"Wong VW et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2012;107(12):1862\u201371.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"329_CR74","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VW Wong","year":"2010","unstructured":"Wong VW et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454\u201362.","journal-title":"Hepatology"},{"issue":"5","key":"329_CR75","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.dld.2007.10.019","volume":"40","author":"M Yoneda","year":"2008","unstructured":"Yoneda M et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis. 2008;40(5):371\u20138.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"329_CR76","first-page":"53","volume":"19","author":"M Lupsor","year":"2010","unstructured":"Lupsor M et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis. 2010;19(1):53\u201360.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"12","key":"329_CR77","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2008.03701.x","volume":"27","author":"C Bureau","year":"2008","unstructured":"Bureau C et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008;27(12):1261\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"329_CR78","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1365-2036.2008.03825.x","volume":"28","author":"M Lemoine","year":"2008","unstructured":"Lemoine M et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther. 2008;28(9):1102\u201310.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"329_CR79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/liv.12003","volume":"33","author":"KQ Shi","year":"2013","unstructured":"Shi KQ et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 2013;33(1):62\u201371.","journal-title":"Liver Int"},{"issue":"5","key":"329_CR80","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.21665","volume":"45","author":"F Vizzutti","year":"2007","unstructured":"Vizzutti F et al. Liver stiffness measurement predicts severe portal hypertension in patients with hcv-related cirrhosis. Hepatology. 2007;45(5):1290\u20137.","journal-title":"Hepatology"},{"issue":"3","key":"329_CR81","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","volume":"143","author":"A Colecchia","year":"2012","unstructured":"Colecchia A et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology. 2012;143(3):646\u201354.","journal-title":"Gastroenterology"},{"issue":"6","key":"329_CR82","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.22870","volume":"49","author":"R Masuzaki","year":"2009","unstructured":"Masuzaki R et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology. 2009;49(6):1954\u201361.","journal-title":"Hepatology"},{"issue":"3","key":"329_CR83","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.24121","volume":"53","author":"KS Jung","year":"2011","unstructured":"Jung KS et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 2011;53(3):885\u201394.","journal-title":"Hepatology"},{"issue":"5","key":"329_CR84","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2011.01.051","volume":"55","author":"MA Robic","year":"2011","unstructured":"Robic MA et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol. 2011;55(5):1017\u201324.","journal-title":"J Hepatol"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-016-0329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-016-0329-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-016-0329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:59:38Z","timestamp":1749034778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-016-0329-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1007\/s11904-016-0329-5","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]}}}